Skip to main content

Award-Winning eClinical Platform Powered by AI | Clinion

CASE STUDY

How Clinion’s Unified eConsent, EDC, ePRO, and eTMF Platform Reduced Workflow Fragmentation in a Phase IV Regenerative Medicine Study

Overview

A Phase IV regenerative medicine study needed a single platform to connect participant consent, clinical follow-up data, quality-of-life responses, and trial documentation.

The study followed 200 participants across treated and control groups, with a 96-page eCRF structure built around long-term safety follow-up, laboratory markers, adverse event tracking, exploratory outcomes, group-wise comparisons, and repeat assessments.

Clinion’s unified eConsent, EDC, ePRO, and eTMF platform brought consent, clinical data, patient outcomes, and trial documentation into one study environment. EDC managed the 96-page dataset with reusable eCRFs, edit checks, discrepancy review, bulk queries, and study reports, while ePRO captured quality-of-life responses and eTMF kept document completeness, versions, and inspection readiness visible throughout the study.

Study Snapshot

Client & Industry
Industry
Biotech
Client
Regenerative medicine sponsor
Study Design
Study Type
Interventional
Therapeutic Area
Regenerative Medicine
Study Phase
Phase IV
Randomization
Non-randomized
Study Design
Long-term follow-up study comparing previously treated participants with a non-treated control group
Scale & Geography
Region
Sweden
Site Count
1 site
Regulatory & Delivery
Submission
EU regulatory submission (CTIS), per registry record
Study Duration
Approximately 14 months (As per registry record)
Products Provided

Challenges

Managing eConsent, EDC, ePRO, and eTMF in One Connected Study Workflow

The study needed consent records, clinical follow-up data, quality-of-life responses, and trial documents to stay connected across 200 participants and a 96-page eCRF structure. 

01

Keeping Consent Connected to the Subject Record

Consent status, ICF versions, participant signatures, and subject records needed to stay traceable from onboarding into clinical data capture.

02

Controlling Review Across a Large Follow-Up Dataset

Safety data, lab markers, adverse events, exploratory outcomes, and repeat assessments needed to stay structured and reviewable across the 96-page eCRF build.

03

Keeping ePRO Outcomes and TMF Readiness Visible

Quality-of-life responses and essential trial documents needed to remain easy to track during conduct, not become disconnected items to reconcile later.

Solutions

One Unified Environment for Consent, Clinical Data, and Long-Term Outcomes

Clinion deployed an integrated workflow combining eConsent, EDC, ePRO, and eTMF to support the regenerative medicine study. The platform helped the study team connect participant consent, clinical data, quality-of-life outcomes, and trial documentation in one controlled environment.

Clinion eConsent was configured to support study-specific digital consent forms for participant onboarding. Instead of treating consent as a separate paper or PDF process, Clinion used its eConsent workflow to connect consent review, participant signature, investigator approval, and subject enrollment into the downstream study workflow.

Clinion helped by using:

  • Multimedia-driven consent workflows to make study information easier for participants to understand
  • ICF version control to keep current and previous consent versions traceable
  • Time-stamped digital signatures for participant consent records
  • Investigator review and approval before participant progression
  • Automated compliance tracking for consent status and version history
  • Automatic EDC enrollment after consent completion, reducing manual subject setup

This made consent the first connected step in the study workflow, rather than a document that had to be manually tracked and later matched to the clinical record.

Clinion EDC was configured to manage a large eCRF build for 200 participants, with 96 eCRF pages supporting safety events, adverse events, laboratory markers, exploratory outcomes, quality-of-life linkage, and follow-up assessments. At this scale, every participant record carried a substantial number of data points that had to remain complete, structured, and reviewable throughout the study.

Clinion helped by using:

  • Standardized Global Library components to speed up study-specific eCRF configuration
  • Reusable form structures for repeated follow-up, safety, lab, and AE data
  • Custom edit checks and skip logic to reduce missing or inconsistent entries
  • Bulk configuration options to manage a large eCRF build more efficiently
  • Data review workflows to detect gaps across safety, lab, AE, and follow-up data
  • Bulk query or correction workflows for recurring data issues
  • AI Report Generator capabilities for faster completion, review-status, and follow-up reports
  • In-platform support through CliniBot to help users resolve product or CRF workflow questions faster

This positioned Clinion EDC as more than a data-entry system. It gave the sponsor a structured way to build, validate, review, query, and report on a large follow-up dataset without relying on scattered forms or manual trackers.

Clinion ePRO was configured as the participant-facing workflow for quality-of-life data capture. Instead of asking participants to complete paper questionnaires or requiring sites to collect and transcribe responses, the Clinion ePRO app gave participants an easy digital interface to complete study questionnaires from their own device.

Clinion helped by using:

  • Easy-to-use mobile and web access for participant-entered responses
  • Study-specific quality-of-life questionnaire configuration
  • Automated reminders to reduce missed questionnaire completion
  • Real-time field validation to reduce incomplete or incorrect responses
  • Direct sync with Clinion EDC so ePRO responses stayed linked to the clinical record
  • Completion visibility for study teams to identify pending or missing responses
  • Review workflows to follow up on incomplete or inconsistent patient-reported data

This made patient-reported data easier to collect and easier to review. Quality-of-life responses came directly from participants through a guided app workflow, reducing paper handling, site-led transcription, and later reconciliation with the EDC dataset.

Clinion eTMF was configured to keep study documentation current during conduct, not only at closeout. For a regulated regenerative medicine study, the sponsor needed protocol files, consent-related documents, regulatory records, approvals, and study lifecycle documents to remain visible, version-controlled, and inspection-ready.

Clinion helped by using:

  • A study-specific TMF file plan with document expectations defined upfront
  • DIA or sponsor-specific TMF structure to match study requirements
  • Document upload, review, QC, and approval workflows
  • Version history and document status tracking
  • Live tracking to flag missing or delayed documents
  • TMF dashboards for completeness, timeliness, quality, and study compliance
  • Lock and archive workflows for closeout readiness

This reduced the risk of late-stage TMF cleanup. Instead of discovering missing documents near closeout, the sponsor could track completeness during the study and keep essential records inspection-ready across the lifecycle.

Outcomes

Core Results

Clinion helped the sponsor run a long-term regenerative medicine study with fewer manual handoffs, cleaner follow-up data flow, and stronger inspection readiness. 

Consent-to-Capture Continuity

eConsent and EDC connected digital consent with structured study data capture.

Follow-Up Data Control

EDC and ePRO kept safety, lab, AE, and quality-of-life data connected for easier review.

Live Documentation Oversight

eTMF helped track document completeness, versions, and approvals during study conduct.

Unlock the Future of Clinical Trials with Clinion.

Cut your trial costs by 35% and accelerate your time-to-market by 30%

Compliance

Fully Compliant with Global Standards

Clinion global compliance badges including FDA 21 CFR Part 11, HIPAA, ISO, ICH, GDPR, and EU compliance
ich ,gdpr ,eu compliant logos
Clinion’s adherence to global regulatory standards including FDA 21 CFR Part 11, HIPAA, ISO 9001:2015, ISO 27001:2013, ICH, GDPR, and EU Annex 11.